Thyroid Associated Ophthalmopathies Clinical Trials

11 clinical trials for Thyroid Associated Ophthalmopathies across international registries, including 6 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Screening, Classification, and Outcome Prediction Ensemble Using Orbital MRI for Thyroid Eye Disease: The TED SCOPE National Multicenter Registry Study — RECRUITING
• MHB018A Treatment in Patients With Active Thyroid Eye Disease — RECRUITING · PHASE3
• Eye Tracking Study on Eye Movement Function and Visual Attention Patterns in Patients With Thyroid-Associated Ophthalmopathy — RECRUITING
• Evaluation of the Efficacy and Safety Observation of IBI311 Treatment in Patients With Inactive TAO — RECRUITING · PHASE4
• Efficacy and Safety of Sequential Hormone Therapy and Tetuzumab Therapy in Patients With Moderate to Severe TAO in the Active Stage After Glucocorticoid Treatment. — RECRUITING · PHASE4
• The Safety and Efficacy of Sequential Hormone Therapy and IBI311 Therapy in Patients With Active Moderate to Severe TAO in the Initial Treatment. — RECRUITING · PHASE4
• Prospective Observational Study of Smartphone-Based AI Self-Monitoring During Non-Surgical Treatment for Thyroid Eye Disease (THYROSCOPE) — NOT_YET_RECRUITING
• Teprotumumab (RV 001) Treatment in Patients With Active Thyroid Eye Disease — COMPLETED · PHASE2
• Selenium in Mild Thyroid Eye Disease in North America — WITHDRAWN · PHASE3
• Treatment of Soft Tissue Expansion in Inactive Thyroid Eye Disease Patients Using Drops of Prostaglandin Analogues — COMPLETED · PHASE3
• Tocilizumab Treatment in Graves´ Ophthalmopathy (Graves´ Orbitopathy or Thyroid Eye Disease) — COMPLETED · PHASE3

Refine this search